New data in myelodysplastic syndromes

4 Views
administrator
administrator
07/04/23

Speaking from the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL, Valeria Santini, MD, University of Florence, Florence, Italy, discusses the latest updates in myelodysplastic syndromes (MDS). She highlights a range of new therapeutic approaches, including rigosertib, roxadustat, and the combination of venetoclax with hypomethylating agents.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next